tardive dyskinesia


Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to tardive dyskinesia: neuroleptic malignant syndrome, tardive dystonia
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to tardive dyskinesia

involuntary rolling of the tongue and twitching of the face or trunk or limbs

Related Words

References in periodicals archive ?
The company markets Ingrezza (valbenazine) capsules in the US for the treatment of adults with tardive dyskinesia.
ABSTRACT 414 Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Efficacy, Safety and Tolerability of Fixed-Dose Deutetrabenazine for the Treatment of Tardive Dyskinesia (Poster Session June 6; 1:45pm-3:15pm) K.
Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.
Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia.
After around four months of treatment patient was found to have Tardive Dyskinesia.
With chronic use, they develop drug-induced parkinsonism or tardive dyskinesia," Dr.
After 6 months, residents should be reevaluated for a possible dose reduction and for any signs of side effects such as tardive dyskinesia.
Repeated drug "holidays" lasting several months at a time do not prevent -- and may indeed worsen -- tardive dyskinesia, Jeste and his colleagues contend in the March Archives of General Psychiatry.
Auspex is developing SD-809 for the treatment of hyperkinetic movement disorders including Huntington's disease, Tourette syndrome and tardive dyskinesia.
Israeli pharmaceutical firm Teva (TLV: TEVA)'s Austedo has become the first and only Huntington's disease medication that treats both tardive dyskinesia and chorea to be approved in the US, the company said on Wednesday.
Despite improvements in the tolerability of antipsychotic medications, the development of tardive dyskinesia (TD) still is a significant area of concern; however, clinicians have had few treatment options.
The ARM-TD study evaluated the safety and efficacy of the investigational use of deutetrabenazine (SD-809) compared to placebo in the treatment of moderate to severe tardive dyskinesia (TD).
This antipsychotic-induced dystonia is considered a subtype of tardive dyskinesia.
The common use of atypical antipsychotics in this age group may lead to various consequences, including movement disorders, such as tardive dyskinesia (TD).
Tardive Dyskinesia Global Clinical Trials Review, H1, 2013